Medline Inc. Class A Common Stock (MDLN)vsWarby Parker Inc (WRBY)
MDLN
Medline Inc. Class A Common Stock
$42.67
+1.52%
HEALTHCARE · Cap: $34.68B
WRBY
Warby Parker Inc
$23.38
+1.39%
HEALTHCARE · Cap: $2.86B
Smart Verdict
WallStSmart Research — data-driven comparison
Medline Inc. Class A Common Stock generates 3161% more annual revenue ($28.43B vs $871.90M). WRBY leads profitability with a 19.0% profit margin vs 4.1%. MDLN trades at a lower P/E of 29.9x. MDLN earns a higher WallStSmart Score of 52/100 (C-).
MDLN
Buy52
out of 100
Grade: C-
WRBY
Avoid34
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+32.7%
Fair Value
$66.92
Current Price
$42.67
$24.25 discount
Margin of Safety
-31314.3%
Fair Value
$0.07
Current Price
$23.38
$23.31 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Every $100 of equity generates 46 in profit
Areas to Watch
Moderate valuation
ROE of 6.5% — below average capital efficiency
4.1% margin — thin
Negative free cash flow — burning cash
0.0% earnings growth
Weak financial health signals
Premium valuation, high expectations priced in
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : MDLN
Revenue growth of 14.8% demonstrates continued momentum.
Bull Case : WRBY
The strongest argument for WRBY centers on Return on Equity. Profitability is solid with margins at 19.0% and operating margin at -4.5%. Revenue growth of 11.2% demonstrates continued momentum.
Bear Case : MDLN
The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.
Bear Case : WRBY
The primary concerns for WRBY are EPS Growth, Piotroski F-Score, P/E Ratio. A P/E of 2338.0x leaves little room for execution misses.
Key Dynamics to Monitor
MDLN profiles as a value stock while WRBY is a mature play — different risk/reward profiles.
MDLN is growing revenue faster at 14.8% — sustainability is the question.
WRBY generates stronger free cash flow (8M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MDLN scores higher overall (52/100 vs 34/100) and 14.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Medline Inc. Class A Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.
Visit Website →Warby Parker Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Warby Parker Inc. is an innovative leader in the direct-to-consumer eyewear market, redefining the optical landscape since its founding in 2010. By seamlessly blending a robust online platform with a growing number of physical retail outlets, the company enhances customer engagement while maintaining a focus on stylish, affordable prescription eyewear and sunglasses. Warby Parker's commitment to social impact is exemplified by its "Buy a Pair, Give a Pair" initiative, which fosters community support by providing eyewear to those in need. With a unique brand identity and forward-thinking marketing strategies, Warby Parker is well-positioned for continued expansion and enduring success in the competitive eyewear industry.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?